The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
Abstract
The liver is not oblivious to the passage of time, as ageing is a major risk factor for the development of acute and chronic liver diseases. Ageing produces alterations in all hepatic cells, affecting their phenotype and function and worsening the prognosis of liver disease. The ageing process also implies the accumulation of a cellular state characterized by a persistent proliferation arrest and a specific secretory phenotype named cellular senescence. Indeed, senescent cells have key roles in many physiological processes; however, their accumulation owing to ageing or pathological conditions contributes to the damage occurring in chronic diseases. The aim of this Review is to provide an updated description of the pathophysiological events in which hepatic senescent cells are involved and their role in liver disease progression. Finally, we discuss novel geroscience therapies that could be applied to prevent or improve liver diseases and age-mediated hepatic deregulations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cellular senescence, a stress-induced program causing stable cell-cycle arrest, is a hallmark of liver aging, fibrosis, and cancer.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [3]
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“This type of cancer is primarily associated with risk factors such as HBC and HCV infections, excessive alcohol consumption and obesity, which substantially contribute to its pathogenesis 136 .”
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 5×
“Conversely, HSCs lacking functional p53 secrete specific factors that facilitate the polarization of macrophages towards a tumour-promoting phenotype through the secretion of IL-33, therefore enhancing the proliferation of premalignant cells 93–95 .”
InfluentialHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · cited 1×
“…of TP53 (coding for p53) and different cyclin-dependent kinase (CDK) inhibitors, such as p16 and p21, which results in persistent activation of the retinoblastoma family proteins and the inhibition of transcriptional activators (E2F family) that are required for cell cycle progression 19,20 .”
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 3×
“As described above, SASP encompasses a multitude of factors released by senescent cells, including cytokines, chemokines, interleukins and growth factors, such as IL-1, IL-6, C-C motif chemokine ligand 2 (CCL2) and insulin-like growth factor, among others 24 .”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 6×
“Certainly, within the spectrum delineated by these two contrasting conditions, actively dividing cells can transition into alternative states, including cellular senescence 1 .”
InfluentialMechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Notably, this contradicts what is observed during liver dysfunction, in which the loss of lipid droplets is a characteristic of HSC activation 89 .”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 4×
“…of MASLD in HFD-fed mice through the hepatic accumulation of so-called albumosomes — spherical shell-like structures in the cytoplasm formed by prefolding albumin — which can trap prefolding carnitine palmi-toyltransferase 2 thereby maintaining mitochondrial homeostasis from exhaustion 149 .”
Influential
Cited by
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Metformin decelerates aging clock in male monkeys
Yang, Y., Lu, X., Liu, N., Ma, S., Zhang, H., Zhang, Z., Yang, K., Jiang, M., Zheng, Z., Qiao, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.021 · Cited by 227
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 121
Couteur, D. G. L., Ngu, M., Hunt, N. J., Brandon, A. E., Simpson, S. J., & Cogger, V. C. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01099-z · Cited by 89
“Cellular senescence Ageing 19,112,245 Cellular senescence detected in all liver cell types, including hepatocytes HCC 6,246 Senescence is protective against HCC initiation by reducing cellular proliferation Secretion of inflammatory cytokines (SASP) contributes to inflammation in chronic liver…”
Metadata
- Authors
- Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2024-03-14
- Volume
- 21
- Issue
- 7
- Pages
- 477-492
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4392817758
- Cited by
- 117
- References
- 187
- Citations by year
- 2026: 65 · 2025: 42 · 2024: 10
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, chronic liver disease, hepatocellular carcinoma, senescence-associated secretory phenotype, senolytics, liver disease progression
- MeSH terms
- Aging, Humans, Liver, Liver Diseases, Cellular Senescence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell senescence in liver diseases: pathological mechanism and theranostic opportunity. https://app.cochat.ai/papers/10.1038/s41575-024-00913-4
- The paper
- Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024). Cell senescence in liver diseases: pathological mechanism and theranostic opportunity. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-024-00913-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.